Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Saiprasad, Dasugari"'
Autor:
Varakala, Saiprasad Dasugari, Reshma, Rudraraju Srilakshmi, Schnell, Robert, Dharmarajan, Sriram
Publikováno v:
In European Journal of Medicinal Chemistry 15 January 2022 228
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Chirra, Nagaraju, Shanigarapu, Varshitha, Pedapati, Ravi Kumar, Varakala, Saiprasad Dasugari, Bollikanda, Rakesh K., Sriram, Dharmarajan, Sridhar, Balasubramanian, Kantevari, Srinivas
Publikováno v:
ChemistrySelect; 3/26/2024, Vol. 9 Issue 12, p1-11, 11p
Autor:
Komal G. Sangu, Saiprasad Dasugari varakala, Eruva Vamshi Krishna, Abdul Akhir, Deepanshi Saxena, Mohammad Naiyaz Ahmad, Sidharth Chopra, Sunil Misra, Dharmarajan Sriram, Haridas B. Rode
Publikováno v:
ChemistrySelect. 8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4653202a46924d466490601e85f0137d
https://doi.org/10.1002/slct.202204186
https://doi.org/10.1002/slct.202204186
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
European Journal of Medicinal Chemistry. 228:113976
Our previous studies on FabG have identified two compounds 5-bromo-2-(thiophene-2-carboxamido) benzoic acid (A) and ethyl 6-bromo-2-((dimethylamino)methyl)-5-hydroxy-1-phenyl-1H-indole-3-carboxylate(B) as best hits with allosteric mode of inhibition.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e96fc5837bea095dd7d7e8aabbecffd3
https://doi.org/10.1016/j.ejmech.2021.113976
https://doi.org/10.1016/j.ejmech.2021.113976
Autor:
Nicolò Scalacci, Saiprasad Dasugari, Parisa Nakhostin Mortazavi, Sanjib Bhakta, Alistair K. Brown, Elena Petricci, Arundhati Maitra, Fabrizio Manetti, Daniele Castagnolo, Timothy D. McHugh, Alexander Twist, Dimitrios Evangelopoulos
Publikováno v:
Journal of Medicinal Chemistry. 59:2780-2793
Novel pyrroles have been designed, synthesized, and evaluated against mycobacterial strains. The pyrroles have originally been designed as hybrids of the antitubercular drugs BM212 (1) and SQ109 (2), which showed common chemical features with very si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::506da400a33d5396025d0aa11e371c61
https://doi.org/10.1021/acs.jmedchem.6b00031
https://doi.org/10.1021/acs.jmedchem.6b00031
Autor:
Sanjib, Bhakta, Nicolò, Scalacci, Arundhati, Maitra, Alistair K, Brown, Saiprasad, Dasugari, Dimitrios, Evangelopoulos, Timothy D, McHugh, Parisa N, Mortazavi, Alexander, Twist, Elena, Petricci, Fabrizio, Manetti, Daniele, Castagnolo
Novel pyrroles have been designed, synthesized, and evaluated against mycobacterial strains. The pyrroles have originally been designed as hybrids of the antitubercular drugs BM212 (1) and SQ109 (2), which showed common chemical features with very si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::973730e3d7e3f5ff17feba594a2ee156
http://hdl.handle.net/11365/991423
http://hdl.handle.net/11365/991423
